CVS Group (LON:CVSG) Earns Hold Rating from Shore Capital Group

CVS Group (LON:CVSG)‘s stock had its “hold” rating reiterated by analysts at Shore Capital Group in a report issued on Thursday, September 24th, MarketBeat.com reports. They presently have a GBX 1,400 price objective on the stock. Shore Capital Group’s target price points to a potential upside of 22.06% from the company’s previous close.

CVSG has been the subject of several other research reports. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a GBX 1,700 price objective on shares of CVS Group in a report on Monday, July 27th. Jefferies Financial Group lifted their price target on shares of CVS Group from GBX 1,350 to GBX 1,400 and gave the company a “hold” rating in a report on Friday, July 31st. Finally, Berenberg Bank restated a “buy” rating and issued a GBX 2,000 price objective on shares of CVS Group in a report on Thursday, September 24th. Four analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of GBX 1,666.67.

CVS Group Trading Down 5.9%

Shares of CVSG stock traded down GBX 72 during mid-day trading on Thursday, reaching GBX 1,147. The stock had a trading volume of 341,284 shares, compared to its average volume of 877,581. The firm has a market capitalization of £779.62 million, a PE ratio of 16.65, a price-to-earnings-growth ratio of 1.77 and a beta of 1.07. The stock’s 50-day moving average price is GBX 1,283.30 and its two-hundred day moving average price is GBX 1,228.61. The company has a current ratio of 1.18, a quick ratio of 0.90 and a debt-to-equity ratio of 110.41. CVS Group has a 52-week low of GBX 1,062 and a 52-week high of GBX 1,648.

CVS Group (LON:CVSG) last posted its earnings results on Thursday, September 24th. The company reported GBX 85.60 earnings per share for the quarter. CVS Group had a net margin of 2.43% and a return on equity of 5.91%. Equities analysts expect that CVS Group will post 93.9393939 earnings per share for the current fiscal year.

Insider Activity at CVS Group

In other news, insider Robin Alfonso purchased 768 shares of CVS Group stock in a transaction that occurred on Thursday, August 6th. The shares were bought at an average cost of GBX 1,294 per share, with a total value of £9,937.92. Also, insider Joanne Shaw bought 1,592 shares of the company’s stock in a transaction dated Monday, August 10th. The shares were acquired at an average price of GBX 1,287 per share, for a total transaction of £20,489.04. Insiders have bought 3,860 shares of company stock worth $4,956,696 over the last ninety days. 1.48% of the stock is owned by corporate insiders.

About CVS Group

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.